Status:
COMPLETED
Evaluation of a Metabolic Preparation by a Low-carbohydrate Diet as Atkins-diet to Help in Detecting Infective Endocarditis by 18F-FDG PET
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Infective Endocarditis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Infectious endocarditis (IE) is a pathology where the mortality rate of between 20 and 25%, but a higher morbidity since 50% of the patients are treated by a valvular surgical procedure. The diagnosis...
Eligibility Criteria
Inclusion
- Hospitalized patients with certainly infective endocarditis (95%) such Duke and Li criteria
- Patients with a social protection system
- No impossibility of performing (18)F-FDG PET (agitated, confused patient, etc)
- Stable clinically
- Adaptive antibiotic therapy for at least 8 days
- No known allergy to making impossible to follow strict carbohydrate diet
Exclusion
- Pregnancy, breastfeeding and woman of childbearing age without effective contraception
- Patients under guardianship or curators.
- No treatment with corticoids, valproate, carbamazepine, phenytoin, phenobarbital, catecholamines
- Unbalanced diabetes (fasting capillary blood glucose \> 1,8 g/l ou 10 mmol/l)
- Patients with known hypersensitivity to 18F-FDG or any component of this product
Key Trial Info
Start Date :
March 19 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 3 2021
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT03465098
Start Date
March 19 2018
End Date
August 3 2021
Last Update
February 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chru Nancy Brabois
Vandœuvre-lès-Nancy, France, 54511